Resources

Most Recent

New CalAIM Resources for Medi-Cal Providers

November 20, 2024

On November 12, 2024, DHCS launched a series of new resources to help providers succeed in California Advancing and Innovating Medi-Cal (CalAIM) opportunities. The resources are available in the Providing Access and Transforming Health (PATH) On-Demand Resource Library and include Medi-Cal Managed Care 101 for Community Supports Providers, Medi-Cal Managed Care 101 for Enhanced Care…

Vote Card: 2022-23 Legislative Session

January 25, 2024

See how each California Senator and Assemblymember voted on key policy bills that mirror the values of CAADPE members.

Webinars

Connecting with Kids: Successful Strategies for Youth Recovery

CAADPE joined with the California Alliance for Families and Children and Catalyst Center to present a webinar featuring community-based provider experts and a youth speaker on best practices for treating substance use disorders in youth:

Matthew Diep - Assistant Program Manager, Mental Health America of California, CAYEN
Jolene Treadway, LCSW - Director, Redwood Community Services, Inc
Jeff Farber - Executive Director, Helpline Youth Counseling
José C. Salazar, Dr.PH - Director of Program Development, Tarzana Treatment Centers
Wayne Garcia, Chief Operating Officer Re-Entry Projects, Amity Foundation

See the recording here (from April 27, 2022).

CAADPE-Hosted Webinar Highlights the Treatment Efficacy of Contingency Management

Covid-19 has exacerbated the impact of substance use disorders in California, resulting in a 49.9% increase in drug overdose deaths in the 12-months ending January 2021. Contingency Management is being used by many providers to benefit patients suffering from SUD, and is the only intervention that has proven effective for stimulant use disorder.

In a webinar hosted by CAADPE on September 29th, Dr. Yuri Maricich, Chief Medical Officer, PEAR Therapeutics, facilitated a discussion on the use of Prescription Digital Therapeutics (PDTs) as a pathway for delivering Contingency Management services. He presented data showing that CM has a broad evidence base in stimulant and opioid use disorder, not only in randomized clinical trials, but also in real world outcomes. He noted that patients who were treated with CM delivered via digital platforms had higher rates of abstinence and treatment adherence, and lower rates of hospital utilization.

See the slides

Impact of COVID-19 on Alcohol Consumption, Demand, and Access to Substance Use Disorder (SUD) Treatment Services

October 2020: This webinar offered an overview of how the COVID-19 public health emergency has led to a rise in individuals consuming alcohol as outlined in an RTI International survey, and what Tarzana Treatment Centers, Inc. has observed in changes in demand for and access to substance use disorder treatment (SUD).

CAADPE extends a special thank you to our guest speakers Dr. Alexander Cowell and William Dowd from RTI International, and Dr. Jose Salazar from Tarzana Treatment Centers, Inc. for joining us and sharing their valuable insights.